AR106364A1 - Derivados de insulina y sus usos médicos - Google Patents

Derivados de insulina y sus usos médicos

Info

Publication number
AR106364A1
AR106364A1 ARP160102592A ARP160102592A AR106364A1 AR 106364 A1 AR106364 A1 AR 106364A1 AR P160102592 A ARP160102592 A AR P160102592A AR P160102592 A ARP160102592 A AR P160102592A AR 106364 A1 AR106364 A1 AR 106364A1
Authority
AR
Argentina
Prior art keywords
derivatives
insulin derivatives
medical uses
diabetes
refers
Prior art date
Application number
ARP160102592A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of AR106364A1 publication Critical patent/AR106364A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La presente es en los campos terapéuticos de fármacos para condiciones médicas relacionadas con la diabetes. Mas específicamente se refiere a derivados acilados de análogos de insulina humana. Provee además composiciones farmacéuticas que comprenden dichos derivados de insulina, y se refiere al uso de dichos derivados para el tratamiento o prevención de condiciones médicas relacionadas con la diabetes.
ARP160102592A 2015-08-25 2016-08-24 Derivados de insulina y sus usos médicos AR106364A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15182282 2015-08-25

Publications (1)

Publication Number Publication Date
AR106364A1 true AR106364A1 (es) 2018-01-10

Family

ID=54007591

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102592A AR106364A1 (es) 2015-08-25 2016-08-24 Derivados de insulina y sus usos médicos

Country Status (15)

Country Link
US (1) US11352406B2 (es)
EP (1) EP3341403B1 (es)
JP (2) JP2018531900A (es)
KR (1) KR20180038049A (es)
CN (1) CN108026157B (es)
AR (1) AR106364A1 (es)
AU (1) AU2016311283B2 (es)
BR (1) BR112018002416A2 (es)
CA (1) CA2996455A1 (es)
ES (1) ES2908373T3 (es)
IL (1) IL257173A (es)
MX (1) MX2018002223A (es)
RU (1) RU2018107727A (es)
TW (1) TW201717998A (es)
WO (1) WO2017032798A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR106364A1 (es) 2015-08-25 2018-01-10 Novo Nordisk As Derivados de insulina y sus usos médicos
MA49896A (fr) 2017-08-17 2020-06-24 Novo Nordisk As Nouveaux analogues d'insuline acylés et leurs utilisations
CN112789289A (zh) 2018-10-05 2021-05-11 诺和诺德股份有限公司 包含胰岛素肽和egf(a)肽的双功能化合物
TW202112397A (zh) 2019-03-29 2021-04-01 丹麥商諾佛．儂迪克股份有限公司 葡萄糖敏感型胰島素衍生物
EP4073096A1 (en) 2019-12-10 2022-10-19 Sanofi A method of forming a conjugate of a sulfonamide and a polypeptide
BR112022009510A2 (pt) * 2019-12-11 2022-08-16 Novo Nordisk As Análogo de insulina, composição farmacêutica, e, método de tratamento, prevenção ou alívio de uma doença ou distúrbio ou condição
US20240025957A1 (en) * 2019-12-30 2024-01-25 Gan & Lee Pharmaceuticals Co., Ltd. Insulin Derivative
KR20240013778A (ko) * 2021-05-24 2024-01-30 선샤인 레이크 파르마 컴퍼니 리미티드 신규한 아실화된 인슐린 유사체

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DK0506792T3 (da) * 1989-12-21 1995-10-09 Novo Nordisk As Insulinpræparat, der indeholder nikotinsyre eller nikotinamid
CA2171424C (en) 1993-09-17 2002-06-04 Svend Havelund Acylated insulin
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
IL114160A (en) 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
US5922678A (en) 1996-06-28 1999-07-13 Eli Lilly And Company Methods for treating diabetes
ES2258797T3 (es) 1996-12-20 2006-09-01 Novo Nordisk A/S Proteinas con extension n-terminal expresadas en la levadura.
ATE321783T1 (de) 1997-03-20 2006-04-15 Novo Nordisk As Zinkfreie insulinkristalle für die verwendung in medikamenten, die über die lunge verabreicht werden.
PL340255A1 (en) * 1997-10-24 2001-01-29 Lilly Co Eli Non-dissolving insulin compositions
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
CN102816228A (zh) 2003-12-03 2012-12-12 诺和诺德公司 单链胰岛素
WO2006097521A1 (en) 2005-03-18 2006-09-21 Novo Nordisk A/S Pegylated single-chain insulin
WO2007096431A1 (en) 2006-02-27 2007-08-30 Novo Nordisk A/S Insulin derivatives
WO2007104738A2 (en) 2006-03-13 2007-09-20 Novo Nordisk A/S Acylated single chain insulin
RU2352113C1 (ru) 2007-06-18 2009-04-20 Владимир Яковлевич Этин Ловушка для эктопаразитов
ITRG20070003A1 (it) * 2007-07-17 2009-01-18 Salvatore Lucifora Metodo e sistema informatico per analizzare le prestazioni e dimensionare una cella underlay/overlay di un sistema di telecomunicazione cellulare
CN101778862B (zh) * 2007-08-13 2014-12-17 诺沃-诺迪斯克有限公司 快速作用的胰岛素类似物
CN101784562B (zh) * 2007-08-15 2016-07-13 诺沃-诺迪斯克有限公司 具有酰基和亚烷基二醇部分的胰岛素类似物
US8962794B2 (en) 2007-08-15 2015-02-24 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
EP2254905B1 (en) 2008-03-14 2016-12-14 Novo Nordisk A/S Protease-stabilized insulin analogues
BRPI0910348B1 (pt) * 2008-03-18 2021-06-29 Novo Nordisk A/S Insulina estabilizada em protease acilada, composição farmacêutica compreendendo a mesma e seus usos
JP5818681B2 (ja) 2008-04-01 2015-11-18 ノボ・ノルデイスク・エー／エス インスリンアルブミンコンジュゲート
EP2448962B1 (en) 2009-06-30 2016-10-19 Novo Nordisk A/S Insulin derivatives
EP2496213B1 (en) 2009-11-02 2015-08-12 Novo Nordisk A/S Pharmaceutical solution of non covalently bound albumin and acylated insulin
WO2011161124A1 (en) 2010-06-23 2011-12-29 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
WO2012015691A2 (en) 2010-07-28 2012-02-02 Smartcells, Inc. Recombinant lectins, binding-site modified lectins and uses thereof
JP2013540771A (ja) * 2010-10-15 2013-11-07 ノヴォ ノルディスク アー／エス 新規ｎ末端修飾インスリン誘導体
JP6058646B2 (ja) 2011-06-15 2017-01-11 ノヴォ ノルディスク アー／エス 多置換インスリン
BR112014010139A2 (pt) 2011-10-27 2017-04-25 Univ Case Western Reserve formulação farmacêutica, método de redução do nível de açúcar no sangue de um paciente e polipeptídeo
CN103443122B (zh) 2011-12-15 2016-05-11 上海恒瑞医药有限公司 人胰岛素类似物及其酰化衍生物
BR112015023071A2 (pt) 2013-03-14 2017-07-18 Univ Indiana Res & Tech Corp conjugados de insulina-incretina
EP3052134B1 (en) 2013-10-04 2021-05-05 Merck Sharp & Dohme Corp. Glucose-responsive insulin conjugates
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
AR106364A1 (es) 2015-08-25 2018-01-10 Novo Nordisk As Derivados de insulina y sus usos médicos
US20190010206A1 (en) 2015-08-25 2019-01-10 Novo Nordisk A/S Novel Insulin Derivatives and the Medical Uses Hereof
CN105440125B (zh) 2015-11-25 2019-09-24 华润昂德生物药业有限公司 地特胰岛素或其类似物的制备方法
WO2019125879A2 (en) 2017-12-18 2019-06-27 Merck Sharp & Dohme Corp. Conjugate based systems for controlled insulin delivery
BR112022009510A2 (pt) 2019-12-11 2022-08-16 Novo Nordisk As Análogo de insulina, composição farmacêutica, e, método de tratamento, prevenção ou alívio de uma doença ou distúrbio ou condição

Also Published As

Publication number Publication date
JP2018531900A (ja) 2018-11-01
AU2016311283B2 (en) 2020-10-08
CN108026157B (zh) 2022-11-25
WO2017032798A1 (en) 2017-03-02
AU2016311283A1 (en) 2018-02-15
EP3341403B1 (en) 2022-01-05
JP2021177779A (ja) 2021-11-18
US11352406B2 (en) 2022-06-07
US20180305431A1 (en) 2018-10-25
MX2018002223A (es) 2018-03-23
IL257173A (en) 2018-06-28
BR112018002416A2 (pt) 2018-09-18
CN108026157A (zh) 2018-05-11
ES2908373T3 (es) 2022-04-28
TW201717998A (zh) 2017-06-01
EP3341403A1 (en) 2018-07-04
RU2018107727A (ru) 2019-10-01
KR20180038049A (ko) 2018-04-13
CA2996455A1 (en) 2017-03-02
RU2018107727A3 (es) 2019-11-28

Similar Documents

Publication Publication Date Title
AR106364A1 (es) Derivados de insulina y sus usos médicos
ECSP20040257A (es) Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1
AR099569A1 (es) Derivados de insulina y los usos médicos de estos
DOP2015000241A (es) Compuestos de biaril-amida como inhibidores de cinasa
CO2018002060A2 (es) Compuestos farmacéuticos
CL2019001586A1 (es) Insulina que contiene composiciones farmacéuticas.
UY35827A (es) Derivados de triazolopirazina como inhibidores de la proteína brd4
UY35586A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
UY32919A (es) Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
UY36875A (es) Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
DOP2016000170A (es) Compuestos derivados de hidroxiformamida y usos del mismo
ECSP19083930A (es) Compuesto de insulina acilada
CL2019001996A1 (es) Usos terapéuticos de un polvo de insectos.
BR112017023170A2 (pt) dispositivo de banho medicinal e seu uso
SV2016005330A (es) Compuestos de 1,3,4-tiadiazol y uso de los mismos para el tratamiento del cã�ncer
BR112016027435A2 (pt) formulação inovadora de meloxicam
CL2017001539A1 (es) Compuestos indenil, composiciones farmacéuticas y sus usos médicos de los mismos
UY37729A (es) NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
CO2022007273A2 (es) Análogos de insulina novedosos y usos de estos
BR112015021265A2 (pt) métodos de aperfeiçoamento de uso para secretoglobinas humanas recombinantes
CL2019002480A1 (es) Derivados de pirazol como inhibidores de bromodominio.
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.